These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11249571)
21. Current updates on oxazolidinone and its significance. Pandit N; Singla RK; Shrivastava B Int J Med Chem; 2012; 2012():159285. PubMed ID: 25954524 [TBL] [Abstract][Full Text] [Related]
23. Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment. Schwalm JD; El-Helou P; Lee CH Can J Infect Dis; 2004 Mar; 15(2):97-100. PubMed ID: 18159483 [TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria. Yoon EJ; Jo YW; Choi SH; Lee TH; Rhee JK; Yoo M; Shim MJ; Choi EC Antimicrob Agents Chemother; 2005 Jun; 49(6):2498-500. PubMed ID: 15917554 [TBL] [Abstract][Full Text] [Related]
27. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class. Nilius AM Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374 [TBL] [Abstract][Full Text] [Related]
28. Linezolid. Narang M; Gomber S Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662 [TBL] [Abstract][Full Text] [Related]